Split-belt Treadmill Training for Freezing of Gait in Parkinson's Disease
Launched by KU LEUVEN · Aug 19, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Be between 40 - 90 years of age
- • Have a diagnosis of Parkinson's disease
- • Be able to walk for 10 min without an aid
- • Be able to follow and understand the oral instructions of the investigator
- • Have a disease stage of I to IV (while ON-medication)
- • Have had no change in your Parkinson's medication in the past month (or to your deep brain stimulator if applicable) and also no planned changes in medication over the next 4 months
- • Have at least about 1 "freezing" episode per day (based on the New Freezing of Gait Questionnaire: N-FOG)
- • Not participating in another clinical trial
- • Have no acute joint disease
- • Not have any other condition that affects your walking pattern or prevents you from completing all study tasks
- • Have not undergone major surgery or hospitalization in the last 3 months
- • No substance abuse
- • No depressive disorder or other apathetic disorder that precludes daily exercise
About Ku Leuven
KU Leuven, a prestigious research university located in Belgium, is renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KU Leuven integrates cutting-edge research with clinical practice, facilitating the development of new therapeutic strategies and medical technologies. The institution's robust infrastructure and expertise in various fields, including biotechnology, pharmacology, and public health, position it as a leader in conducting high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements. Through its clinical trials, KU Leuven aims to contribute significantly to the global biomedical landscape and enhance health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Patients applied
Trial Officials
Alice Nieuwboer, PhD
Principal Investigator
KU Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials